Akebia Therapeutics Inc (AKBA)

04:55 AM

Is Akebia Therapeutics Inc. stock cheap at current valuation2025 Price Action Summary & Low Drawdown Trading Strategies - newser.com

04:55 AM

Nov 20, 2025

How forex fluctuations impact Akebia Therapeutics Inc. (AX9) stockWeekly Loss Report & Reliable Intraday Trade Plans - newser.com

Nov 20, 2025

Nov 20, 2025

How Akebia Therapeutics Inc. stock compares to market leadersPortfolio Risk Summary & Growth Focused Entry Point Reports - newser.com

Nov 20, 2025

Nov 20, 2025

What analyst consensus implies for Akebia Therapeutics Inc. (AX9) stockCEO Change & AI Forecasted Entry/Exit Points - newser.com

Nov 20, 2025

Nov 19, 2025

Live market analysis of Akebia Therapeutics Inc.Portfolio Gains Report & Real-Time Sentiment Analysis - newser.com

Nov 19, 2025

Nov 19, 2025

How Akebia Therapeutics Inc. (AX9) stock gains from tech spendingTrade Entry Report & Free Verified High Yield Trade Plans - newser.com

Nov 19, 2025

Nov 19, 2025

How Akebia Therapeutics Inc. (AX9) stock behaves in tightening cyclesMarket Volume Summary & Expert Curated Trade Setups - newser.com

Nov 19, 2025

Nov 19, 2025

Signal strength of Akebia Therapeutics Inc. stock in tech scannersJuly 2025 Opening Moves & Low Risk Entry Point Guides - newser.com

Nov 19, 2025

Nov 19, 2025

Is Akebia Therapeutics Inc. stock a safe investment in uncertain markets2025 AllTime Highs & Low Drawdown Investment Strategies - newser.com

Nov 19, 2025

Nov 19, 2025

How strong dollar benefits Akebia Therapeutics Inc. (AX9) stock - newser.com

Nov 19, 2025

Nov 19, 2025

Tools to assess Akebia Therapeutics Inc.’s risk profileJuly 2025 Weekly Recap & Stock Portfolio Risk Control - newser.com

Nov 19, 2025

Nov 19, 2025

Brokerages Set Akebia Therapeutics, Inc. (NASDAQ:AKBA) Price Target at $6.00 - Defense World

Nov 19, 2025

Nov 18, 2025

This trade activity should not be overlooked: Akebia Therapeutics Inc (AKBA) - Setenews

Nov 18, 2025

Nov 18, 2025

Levi & Korsinsky Announces an Investigation on Behalf of Akebia Therapeutics, Inc. (AKBA) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire

Nov 18, 2025

Nov 17, 2025

AKBA: Vafseo's expanding access and strong clinical data position it for standard of care in dialysis - TradingView

Nov 17, 2025

Nov 17, 2025

Akebia Therapeutics, Inc. Announces Amendment to License Agreement for Drug Supply and Manufacturing Rights - MarketScreener

Nov 17, 2025

Nov 17, 2025

Akebia Therapeutics amends license agreement with Medice for Vafseo supply - Investing.com

Nov 17, 2025

Nov 17, 2025

Akebia Therapeutics amends license agreement with Medice for Vafseo supply By Investing.com - Investing.com South Africa

Nov 17, 2025

Nov 17, 2025

Akebia Therapeutics Inc says on Nov 12, co and Medice amend license agreement - MarketScreener

Nov 17, 2025

Nov 17, 2025

Analyzing Akebia Therapeutics Inc. with risk reward ratio charts2025 Trading Recap & Reliable Breakout Stock Forecasts - newser.com

Nov 17, 2025

Nov 17, 2025

Akebia Therapeutics Shares Extend Decline Amid Analyst Downgrades - Ad-hoc-news.de

Nov 17, 2025

Nov 17, 2025

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Nov 17, 2025

Nov 17, 2025

FY2025 Earnings Forecast for AKBA Issued By Leerink Partnrs - MarketBeat

Nov 17, 2025

Nov 17, 2025

Akebia Therapeutics Inc. stock retracement – recovery analysisMarket Performance Recap & Growth Oriented Trading Recommendations - newser.com

Nov 17, 2025

Nov 16, 2025

Shareholders Alert: Investigation Into Akebia Therapeutics, Inc. (AKBA)Contact Levi & Korsinsky to Protect Your Rights - ACCESS Newswire

Nov 16, 2025

Nov 15, 2025

How Akebia Therapeutics Inc. stock reacts to job market data2025 Price Targets & Community Consensus Picks - newser.com

Nov 15, 2025

Nov 15, 2025

Why Akebia Therapeutics Inc. (AX9) stock attracts wealthy investorsExit Point & AI Driven Price Predictions - newser.com

Nov 15, 2025